Book Reviews, Notes and Comments Tropic Drugs Intheancientworld] [Pharmacological Ecstasy

Total Page:16

File Type:pdf, Size:1020Kb

Book Reviews, Notes and Comments Tropic Drugs Intheancientworld] [Pharmacological Ecstasy 376 Ann Ist Super Sanità 2014 | Vol. 50, No. 4: 376-380 DOI: 10.4415/ANN_14_04_14 BOOK REVIEWS, NOTES AND COMMENTS Edited by Federica Napolitani Cheyne TS N 266). Quotes are justified by the infinite variety of dif- OMME L’ESTASI FARMACOLOGICA ferent approaches and theories: to the point that the author has felt the need to discuss (and reject) the opin- C Uso magico-religioso delle droghe D nel mondo antico ion that “altered” states of consciousness simply do not N A exist, being extremes in a continuum of “normal” states. Paolo Nencini In this context it should also be noted that recent times Roma: Giovanni Fioriti Editore; have witnessed an exponential increase of more or less OTES 2014. 238 p. fanciful accounts of Out-of-body experiences and Near- ISBN: 978-88-95930-96.1. death experiences [3] (these are briefly discussed in a , N € 26,00. later chapter, p. 177), resulting in several attempts to provide scientific explanations of such experiences [4]. [Pharmacological ecstasy. Ritual-religious uses of psycho- Additional complications stem from the fact that this EVIEWS tropic drugs in the ancient world] field is strewn with a startling number of chicken-and- R egg questions for which answers are mostly unavailable This book, following those by the same author on opi- (and will remain unavailable), due to the absence or un- OOK um [1] and alcohol [2], completes a trilogy devoted to reliability of prehistorical and historical evidence. For B the historical, sociological, cultural and anthropological example, euroasiatic or indoamerican shamanic expe- aspects of the development of different drug uses from riences may have originally developed without the use prehistoric times to the present. Much of this work de- of drugs, i.e., by steady introspection, intense physical bunks several time-honoured narratives showing, for exertion (dance etc.) and/or stunning sensory stimula- example, that ritual/religious and therapeutical uses of tion (obsessively rhythmic music or drum beating); only opium started a long time before its hedonic uses. later on, drugs may have been introduced as facilitators. This third instalment is a significant contribution to With or without drugs, the importance of the shaman’s the understanding of a variety of phenomena in the functions is further confirmed by recent developments realms of psychology, psychopathology, and either such as the taking on of a political role in defence of therapeutical or non-therapeutical psychotropic drug amerindian communities from external threats [5]. uses. Among other things, the evidence discussed is The second chapter, devoted to the Palaeolithic Age, often against the frequent attribution of a significant is a good example of how the admixture of available role of drugs in the development of various religions as and missing evidence can unleash a host of equally distinct, e.g., from shamanic, magic, or today’s New Age (or almost equally) credible accounts and hypotheses practices. At most, drugs may have favoured group co- in contrastt with each other. For example, the role of hesion in religious practices and/or facilitated the per- drugs – particularly plants containing antimuscarinics formance of one or the other ritual. The discussion of such as atropine and scopolamine – in the production the possible role of drugs and its frequent discounting of Franco-Cantabrian paintings (Altamira, Lascaux, helps understanding the considerable differences be- etc.) is strongly supported by some but firmly denied tween shamanism, magic and wizardry, between Greek by others. Earlier interpretations were often based on mantic (pythonic) practices and Roman divinatory an instrumental (“intercession”) model – the invocation practices, between Jewish prophetism and Christian of animal spirits to favour success in hunting, includ- symbolism, and so on and so forth. ing defence from dangerous neighbours, and to stave In this difficult exercise the author had to negotiate a off the spectre of famine. Incidentally this seems to an- monumental amount of highly heterogeneous literature ticipate innumerable similar phenomena both religious evidence. In fact this field, characterized by a hetero- and non-religious, till recent times, like the cult of the geneous nomenclature – psychedelic, psychotomimetic, Fourteen Intercessor Saints at the spectacular baroque psychodisleptic or hallucinogenic drugs – is much wid- Vierzehnheiligen pilgrimage church in Bavaria. er and diversified than those of opiates and alcoholic Subsequently, more sophisticated, often “cognitive”, beverages. This depends on the wide variety not only hypotheses have been supported and Nencini shows of different drug types (rather than different forms of how each has its pros and contras, including those in- the same type of drug), but also of different settings in volving the use of drugs. Of special interest in the face which their use was developed. of present debates on neuropsychological and psycho- Having to deal with various states of altered con- pathological questions are a “neuro-aesthetic” hypoth- sciousness, the author devotes his first chapter to a clear esis and an “autistic” hypothesis. The latter is based survey of the present controversial knowledge on con- on the sudden appearance in the Paleolythic of a high sciousness and its “normal” and “altered” states (see also quality artistic capability, assuming that such an appar- the recent series of articles in this journal on coma and ently rapid flowering is not an artifact due to missing vegetative states, Ann Ist Super Sanità 2014;50(3):207- evidence on previous more “primitive” attempts: the 377 franco-cantabrian sudden perfection could therefore be spectively) and by “competing” myths (particularly the compared to the sudden emergence of a high-quality one resulting in Orphic mysteries), descent to, and re- drawing capability in some autistic children, without turn from, the Underworld is a crucial aspects of these any previous ad hoc training. The substantial implica- cults, be they associated or not with one or the other tions for the relationships between the development of type of drug use. language and other cognitive capabilities by The last chapter is an effective overview of the de- Homo sapi- TS ens are too complex to be discussed here. velopments from ancient times to the present, showing N For obvious reasons, the contents of the following six the complex relations in the Middle Ages between dif- chapters cannot be discussed in detail. The third one ferent trends – the Neoplatonic, Hermetic and Gnos- concludes in favour of marked differences between tic heritages, Scholastic philosophy and theology ap- OMME the experiences of Middle-east neolithic populations, propriating Aristotle’s wisdom, astrology and alchemy, C D whose use of drugs was likely limited to beer (quite and last but not least, wizardry with its use of drugs N A murky and with a low alcohol contents, therefore con- (particularly those with central antimuscarinic effects) sumed more for its food value than for its inebriating and its long history of persecution of not-sufficiently- properties), and those of the central and western euro- submissive women (overall, about 100,000 trials, up to OTES pean areas, where ample evidence has been found of an 90% of all trials in some places and periods). The fol- extensive use of opium; however, for ritual and perhaps lowing step deals with the apparently bizarre admixture , N therapeutic purposes, not for hedonic purposes. The in the Renaissance of currents like esotericism and the fourth chapter deals with subsequent developments in new paradigms of modern science: Paracelsus’ pharma- the East, including the spread of cannabis domestica- cology and therapeutics is the classical example of such EVIEWS tion and uses (there is evidence of its presence in Chi- a hybridation. This long story ends with a confrontation R na already around 4,500 BC) and of shamanic uses of between modern scientific psychopharmacology and Amanita muscaria in the northeastern euroasiatic area. “New age” trends with their religious dogmas connect- OOK Quite interesting in this chapter is a discussion of the ed to the use of hallucinogens and their philosophies B more or less fanciful attempts to guess what was the which appear to come much closer to the Gnostic than mythical Vedic ritual drink Soma, of importance among the Hermetic tradition – both signs of a strong nostalgia the early Indo-Iranians, for which different investiga- for an (imaginary) past Golden Age. tors have “identified” some 20 different plants and fungi The author concludes his analysis with a harsh judg- with quite different psychotropic properties. ment on the drastic prohibition – following the Timo- The fifth chapter confronts scientific evidence and thy Leary Harvard “scandal” and Leary’s jailing in the legendary accounts concerning Mediterranean areas sixties, another example of the 20th century fixation up to and including the period corresponding to the with witch hunting, shortly after the downfall of Sena- Homeric poems; i.e., ranging from the sudden appear- tor McCarthy – of any use of hallucinogenic drugs in ance, at the end of the second millennium BC, of icono- psychological and psychopathological research, includ- graphic representations of the opium poppy in Minoic ing investigations on their therapeutic potential in some territory to Circe’s wizardry and its neutralization by ap- psychiatric conditions. Here the author forgets to men- propriate antidotes (and here we have the first appear- tion the work by one of the pioneers in this field, the ance of the term pharmakon, but meaning poison, not Italian psychoanalist Emilio Servadio (1904-1995), who medicine). The following chapter is focused on archaic experimented LSD and psilocybin on himself and on and classical Greece, with its wide range of divinatory younger colleagues in training with him (without any (mantic) practices often intertwined with medical-ther- “religious” freak like those of Leary and others), and apeutical practices (iatromantic); and again, the experts gave lucid accounts of the effects of the drugs (see [6] often disagree concerning the role of various drugs and for his biography and bibliography).
Recommended publications
  • Fatty-Acid Binding Proteins Modulate Sleep and Enhance Long-Term Memory Consolidation in Drosophila Jason R
    Washington University School of Medicine Digital Commons@Becker Open Access Publications 2011 Fatty-acid binding proteins modulate sleep and enhance long-term memory consolidation in Drosophila Jason R. Gerstner University of Wisconsin - Madison William M. Vanderheyden Washington University School of Medicine in St. Louis Paul J. Shaw Washington University School of Medicine in St. Louis Charles F. Landry Scarab Genomics Jerry C. P. Yin University of Wisconsin - Madison Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs Part of the Medicine and Health Sciences Commons Recommended Citation Gerstner, Jason R.; Vanderheyden, William M.; Shaw, Paul J.; Landry, Charles F.; and Yin, Jerry C. P., ,"Fatty-acid binding proteins modulate sleep and enhance long-term memory consolidation in Drosophila." PLoS One.,. e15890. (2011). https://digitalcommons.wustl.edu/open_access_pubs/510 This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact [email protected]. Fatty-Acid Binding Proteins Modulate Sleep and Enhance Long-Term Memory Consolidation in Drosophila Jason R. Gerstner1*¤, William M. Vanderheyden2, Paul J. Shaw2, Charles F. Landry3, Jerry C. P. Yin1,4,5* 1 Department of Genetics, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, 2 Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri, United States of America, 3 Scarab Genomics, LLC, Madison, Wisconsin, United States of America, 4 Department of Neurology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, 5 Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America Abstract Sleep is thought to be important for memory consolidation, since sleep deprivation has been shown to interfere with memory processing.
    [Show full text]
  • 2018 Ibangs Meeting: the 20Th Annual Genes, Brain & Behavior Meeting
    5/25/2018 Program for Thursday, May 17th 2018 IBANGS MEETING: THE 20TH ANNUAL GENES, BRAIN & BEHAVIOR MEETING WELCOME PROGRAM INDEXES PROGRAM FOR THURSDAY, MAY 17TH Days: next day all days View: session overview talk overview 08:30-16:00 Session FV: Pre-IBANGS Satellite Meeting, Functional Validation for Neurogenetics Location: Phillips Hall in the Siebens building room 1-11. The Siebens building is located at the Downtown Mayo Clinic Campus (not the Mayo Civic Center). Description:The transformative nature of next generation sequencing has changed how neuroscientists approach genomic sequence variation. Highly multiplexed molecular testing is providing an expanded level of information from which to make informed phenotypic predictions. The importance of this is reflected in the unprecedented expansion of genomic testing to determine the basis of neurologic conditions. Genomic testing results in many instances provide a definitive basis of a neurologic condition. However, in almost a high proportion of cases, the genomic sequencing results are confounded by the ambiguity of variants with uncertain clinical significance. Herein lies the key with which institutions will lead in the area of genomic medicine. There exists a critical need to provide a mechanism by which uncertain findings can be functionally characterized and translated into clinically actionable results. It is within thisr ealm that academic societies such as IBANGS can have a substantial and informative role on the future of clinical research and practice. This symposium will introduce the challenges and opportunities that exist in the field of human clinical neurogenetics and follow this with presentations of active work in the field of functional genetic finding validation for neurogenetics with a look to the future of genomic neurogenetics.
    [Show full text]
  • 2013 BGA Marseille
    2 Behavior Genetics Association The purpose of the Behavior Genetics Association is to promote the scientific study of the interrelationship of genetic mechanisms and behavior, both human and animal; to encourage and aid the education and training of research workers in the field of behavior genetics; and to aid in the dissemination and interpretation to the general public of knowledge concerning the interrelationship of genetics and behavior, and its implications for health and human development and education. For additional information about the Behavior Genetics Association, please contact the Secretary, Valerie Knopik ([email protected]) or visit the website (www.bga.org). EXECUTIVE COMMITTEE Position 2012-2013 2013-2014 President Eric Turkheimer Carol Prescott President-Elect Carol Prescott Paul Lichtenstein Past President Michael Pogue-Geile Eric Turkheimer Secretary Arpana Agrawal Valerie Knopik Treasurer Soo Rhee Soo Rhee Member-at-Large Marleen de Moor Marleen de Moor Member-at-Large Benjamin Neale Benjamin Neale Member-at-Large Tim Bates Matthew Keller 2013 MEETING INFORMATION The 43rd Annual Meeting of the Behavior Genetics Association is being held at Campus Saint Charles Aix Marseille University. Scientific sessions will occur throughout the day June 29 – July 2. The Opening Reception will be in the Garden in front of Amphi Mathématiques Physique (Building 9) from 18:00 to 21:00 on Friday, June 28. The Conference Banquet and Awards Ceremony will be held Monday, July 1 at Fort Ganteaume, beginning with cocktails at 18:30. A Festschrift for Professor Norman Henderson will be held on Tuesday, July 2 in Amphi Mathématiques Physique. Local Hosts: Michèle Carlier and Pierre Roubertoux We thank the following generous contributors to the 2013 student bursaries: Anonymous o Jenae Neiderhiser o Sally Manson Anderson o Michael Pogue-Geile o Timothy Bates o Chandra Reynolds o Norman Henderson o Michael Stallings o Kelly Klump o James R.
    [Show full text]
  • Regulation of Learning by Epha Receptors: a Protein Targeting Study
    The Journal of Neuroscience, November 1, 1999, 19(21):9538–9549 Regulation of Learning by EphA Receptors: a Protein Targeting Study R. Gerlai,1 N. Shinsky,1 A. Shih,1 P. Williams,2 J. Winer,2 M. Armanini,1 B. Cairns,3 J. Winslow,1 W.-Q. Gao,1 and H. S. Phillips1 Genentech, Inc., Departments of 1Neuroscience, 2Research BioAssay, and 3Pathology, South San Francisco, California 94080 EphA family receptor tyrosine kinases and their ephrin-A li- spontaneous alternation and context-dependent fear condi- gands are involved in patterning axonal connections during tioning, sensitive to hippocampal function, whereas activation brain development, but until now a role for these molecules in of EphA by infusion of an agonist immunoadhesin results in the mature brain had not been elucidated. Here, we show that enhanced performance on these tasks. Because the two be- both the EphA5 receptor and its ephrin-A ligands (2 and 5) are havioral tasks have different motivational, perceptual, and mo- expressed in the adult mouse hippocampus, and the EphA5 tor requirements, we infer the changes were not caused by protein is present in a phosphorylated form. Because there are these performance factors but rather to cognitive alterations. no pharmacological agents available for EphA receptors, we We also find bidirectional changes in gene expression and in designed recombinant immunoadhesins that specifically bind electrophysiological measures of synaptic efficacy that corre- to the receptor binding site of the ephrin-A ligand (antagonist) late with the behavioral results. Thus, EphA receptors and their or the ligand binding site of the EphA receptor (agonist) and ligands are implicated as mediators of plasticity in the adult thus target EphA function.
    [Show full text]
  • Reproducibility of Behavioral Phenotypes in Mouse Models - a Short History with Critical and Practical Notes
    Reproducibility of behavioral phenotypes in mouse models - a short history with critical and practical notes Vootele Voikar Neuroscience Center and Laboratory Animal Center, Helsinki Institute of Life Science Correspondence: Mustialankatu 1 G Helsinki, Finland [email protected] Progress in pre-clinical research is built on endorsed by more than 1000 journals so far, reproducible findings, yet reproducibility has awareness of researchers and the quality of different dimensions and even meanings. Indeed, publications have not been sufficiently improved the terms reproducibility, repeatability, and (13-15). In order to facilitate and enhance replicability are often used interchangeably, implementation of the ARRIVE guidelines, a although each has a distinct definition. Moreover, revised version with exhaustive explanation and reproducibility can be discussed at the level of elaborative documentation was recently published methods, analysis, results, or conclusions (1, 2). (16, 17). Despite these differences in definitions and Paradigm shift. Mice and rats are the most dimensions, the main aim for an individual widely used model animals in basic biomedicine. research group is the ability to develop new However, there has been a drastic change in the studies and hypotheses based on firm and reliable relative use of these two rodent species over time findings from previous experiments. In practice (Figure 1). Historically, the rat was the model of this wish is often difficult to accomplish. In this choice for behavioral studies but from the review, issues affecting reproducibility in the field beginning of 1990s a sharp shift from rats to mice of mouse behavioral phenotyping are discussed. took place. Obviously, this was due to rapid Crisis in reproducibility.
    [Show full text]
  • Contcenter for Genomic Regul
    CONTCENTER FOR GENOMIC REGUL CRG SCIENTIFIC STRUCTURE . 4 CRG MANAGEMENT STRUCTURE . 6 CRG SCIENTIFIC ADVISORY BOARD (SAB) . 8 CRG BUSINESS BOARD . 9 YEAR RETROSPECT BY THE DIRECTOR OF THE CRG: MIGUEL BEATO . 10 GENE REGULATION. 14 p Chromatin and gene expression .....................16 p Transcriptional regulation and chromatin remodelling .....19 p Regulation of alternative pre-mRNA splicing during cell . 22 differentiation, development and disease p RNA interference and chromatin regulation . 26 p RNA-protein interactions and regulation . 30 p Regulation of protein synthesis in eukaryotes . 33 p Translational control of gene expression . 36 DIFFERENTIATION AND CANCER ...........................40 p Hematopoietic differentiation and stem cell biology..........42 p Myogenesis.....................................46 p Epigenetics events in cancer.......................49 p Epithelial homeostasis and cancer ...................52 ENTSATION ANNUAL REPORT 2006 GENES AND DISEASE .................................56 p Genetic causes of disease .............................58 p Gene therapy ......................................63 p Murine models of disease .............................66 p Neurobehavioral phenotyping of mouse models of disease .....68 p Gene function ......................................73 p Associated Core Facility: Genotyping Unit..................76 BIOINFORMATICS AND GENOMICS ..........................80 p Bioinformatics and genomics ...........................82 p Genomic analysis of development and disease ..............86
    [Show full text]
  • 2009 Program
    International Behavioral Neuroscience Society Annual Meeting Program and Abstracts Nassau, The Bahamas June 9-14, 2009 Abstracts of the International Behavioral Neuroscience Society, Volume 18, June 2009 TABLE OF CONTENTS Abstracts....................................................................................................................... 23-66 Acknowledgments................................................................................................................5 Call for 2010 Symposium Proposals....................................................................................7 Advertisements............................................................................................................. 71-75 Author Index ................................................................................................................ 67-70 Exhibitors/Sponsors .............................................................................................................4 Future Meetings...................................................................................................Back Cover Officers/Council...................................................................................................................2 Program/Schedule .......................................................................................................... 8-22 Summary Program ...................................................................................Inside Back Cover Travel Awards......................................................................................................................3
    [Show full text]
  • L'universite Bordeaux 1
    N°d’ordre : 3749 THESE PRESENTEE A L’UNIVERSITE BORDEAUX 1 ECOLE DOCTORALE SCIENCES DE LA VIE ET DE LA SANTE PAR Maude BERNARDET POUR L’OBTENTION DU GRADE DE DOCTEUR SPECIALITE: NEUROSCIENCES ETUDE DES TRAITS AUTISTIQUES CHEZ UN MODELE SOURIS DU X FRAGILE Soutenue publiquement le 16 décembre 2008 devant la commission d’examen constituée par : Catherine Belzung, Pr Rapporteur externe Pascal Branchereau, Pr Président du jury Georges Chapouthier, DR Rapporteur externe Wim Crusio, DR Directeur de thèse Tobias Hévor, Pr Membre invité Pierre Mormède, DR Membre invité Remerciements Je tiens en premier lieu à remercier Georges Di Scala de m’avoir accueillie au sein du Laboratoire de Neurosciences Cognitives et le remercie également de nos conversations scientifiques et non scientifiques. Il a été pour moi un directeur de laboratoire présent et attentionné, sur le soutien duquel j’ai pu compter tout au long de mon cursus dans ce laboratoire. Merci à Wim de m’avoir donné l’opportunité de travailler avec lui et de m’avoir guidée dans mes premiers pas de chercheurs. Je le remercie également de sa disponibilité et de sa joie de vivre la science. On vous dit quand la pression monte et que l’échéance pour rendre le manuscrit approche: ce n’est qu’une thèse, personne ne la lira. Bizarrement ça ne diminue pas la tension créatrice. C’est pourquoi je suis infiniment reconnaissante à mes rapporteurs Catherine Belzung et Georges Chapouthier d’avoir pris le temps de lire et de critiquer mon travail, ainsi qu’à Pierre Mormède, Tobias Hévor et Pascal Branchereau d’avoir accepté de participer à mon jury de thèse.
    [Show full text]
  • Virtual FENS Forum Mini Conference “Behavioural
    Virtual FENS Forum mini conference “Behavioural neuroscience for the next decade: Why behaviour matters to brain science" Saturday 11th July 2020 - 09:00-12:30 (CEST) The European Brain and Behaviour Society (EBBS), European Behavioural Pharmacology Society (EBPS), European Molecular and Cellular Cognition Society (EMCCS) and International Behavioural and Neural Genetics Society (IBANGS) invite you to our jointly organised mini conference. A variety of topics will be covered, focussing on the role of behaviour in Neuroscience and the translatability of animal models to human traits and psychiatric disorders. There will be four themed sessions with talks from rising stars in our field, followed by Q&A. Our mini conference is a rare event bringing together our four societies, established leaders and early career researchers from the behavioural neuroscience community for a day of amazing science and networking opportunities. Supported by the FENS Forum, our mini conference will take place directly before the opening of the virtual FENS Forum meeting. Our mini conference is free to attend but we do ask you to register for the mini conference so we can arrange your online access login. You will be able to enjoy both our mini conference and the full FENS Forum programme on Saturday, 11th July 2020. (Registration will be automatically open to all the registered participants of the full FENS Forum). [Mini conference co-organisers: Francesca Cirulli (EBBS), Wim Crusio (IBANGS), Cathy Fernandes (IBANGS), Andre Fischer (EMCCS), Mathias Schmidt (EBBS) & Louk Vanderschuren (EBPS)] Programme Overview: 09:00-09:50 Topic 1 (EBBS): Progress in complex behavioural analysis (Chair: Mathias Schmidt) 1.
    [Show full text]
  • Ibangs 2021: Genes, Brain and Behavior 2021
    6/4/2021 TRAINEE SYMPOSIUM ITINERARY IBANGS 2021: GENES, BRAIN AND BEHAVIOR 2021 SPONSORS TRAINEE SYMPOSIUM MACHINE LEARNING WORKSHOP POSTER MAP PROGRAM AUTHORS KEYWORDS SLIDES TRAINEE SYMPOSIUM ITINERARY First Annual IBANGS Trainee Symposium on Monday, May 10th at 11am EDT 11:00am-11:15am Welcome 11:15am-12:15pm Science Grant Panel: Dr. Anna-Lisa Lucido, Director, Research Program Development, Jackson Laboratory Dr. Lisa Tarantino, Associate Professor, University of Carolina at Chapel Hill Dr. Amy Lasek, Associate Professor, University of Chicago at Illinois Dr. Marina Guizetti, Professor, Oregon Health and Science University 12:15pm-13:15pm Trainee Talks: 12:15pm: Dr. Ana Filošević Vujnović, Postdoctoral Fellow, University of Rijeka 12:30pm: Julie Sadino, Graduate Student, University of Colorado, Boulder 12:45pm: Miriam Menken, Graduate Student, University of Maryland, Baltimore 13:00pm-13:15pm Data Blitz Saeedeh Hosseinian, Graduate Student, Queen Mary University of London Hayley Thorpe, Graduate Student, University of Guelph https://easychair.org/smart-program/IBANGS2021/traineesymp.html 1/3 6/4/2021 TRAINEE SYMPOSIUM ITINERARY 13:15-13:30pm Break in Walkabout 13:30pm-14:30pm Trainee Talks: 13:30pm: Lucy Hall, Graduate Student, University of Colorado, Boulder 13:45pm: Antonios Diab, Postdoctoral Fellow, Dalhousie University 14:00pm-14:15pm Data Blitz Elam Cutts, Post baccalaureate Student, University of Alabama, Birmingham Elizabeth Brown, Postdoctoral Fellow, Florida Atlantic University Jacob Beierle, Graduate Student, Boston University 14:15-14:30pm Break in Walkabout 14:30pm-15:30pm Science Career Panel: Dr. George Inglis, Communications Biology Editor Dr. Sadie Nennig, Medical Science Liaison, Bristol Meyers Squibb Dr. Megan Mulligan, Assistant Professor, University of Tennessee Health Science Center Dr.
    [Show full text]
  • 2002 Tours, FRANCE
    INTERNATIONAL BEHAVIOURAL AND NEURAL GENETICSOCIETY Fifth Annual Meeting July 11-12, 2002 Université F Rabelais, Faculté de Pharmacie Tours, France Local Organizing Committee: Catherine Belzung (Tours, France) Sabine Richard (Tours, France) Christian Andres (Tours, France) Scientific Program Committee: Catherine Belzung (Tours, France; Chair ) John C. Crabbe (Portland, OR, USA) Wim E. Crusio (Worcester, MA, USA) Mara Dierssen (Barcelona, Spain) Pierre Mormède (Bordeaux, France) Thomas Steckler (Beerse, Belgium) Fred van Leuven (Leuven, Belgium) Douglas Wahlsten (Edmonton, Canada) David Wolfer (Zurich, Switzerland) The meeting was generously sponsored by : Université F Rabelais, Tours Conseil Général d’Indre et Loire Program and Abstracts IBANGS 5th Annual Meeting – 2002 Page 1 Program July 11th 2002 9.00-11.00 Symposium: Down syndrome: from genes to humans, organized by Mara Dierssen (Barcelona, Spain); Chair Mara Dierssen (Barcelona, Spain) 9.00-9.30: Jean Delabar (Paris, France), "Brain phenotypes of DCR1 YAC transgenic mice" 9.30-10.00: I. Ballesteros-Yáñez (Spain) ”Implication of Dyrk1a (minibrain) in morphological alterations of cortical pyramidal neurons associated with Down syndrome.” 10.00-10.30 Ceri Davies (UK), "What do murine genetic models of Down syndrome and Alzheimer's disease actually model?" 10.30-11.00 Mara Dierssen (Barcelona, Spain), "Single gene transgenics and their contribution to the understanding of Down syndrome phenotype". 11.00-11.30 coffee 11.30-12.30 Poster session List of posters at the end of the program
    [Show full text]
  • Scientific and Social Program
    Scientifi c and Social Program Friday, 9th 2011 Saturday, 10th 2011 Sunday, 11th 2011 Monday, 12th 2011 ataGlance Programme 43 REGISTRATION DESK (Registration Area) 8:30-19:30 EBBS - Meeting Seville (2011) BehaviourSocietyMeeting S2A Fear-based Anticipation: S4A It takes two to tango - specialization and S6A Brain oscillations and ontogenesis, networks and cooperation of the two cerebral hemispheres hippocampal memory processing mechanisms in humans and other animals Giralda I-II Giralda I-II Giralda I-II 9:00-11:00 S2B Neural processing of S4B Adenosine receptors as therapeutic S6B Neural bases of cognitive- rd SATELLITE Symposium communication sounds across the targets in brain disorders emotional interactions in humans European Brainand European on "Neurobiology of Time species Perception: from normality Santa Cruz Santa Cruz Santa Cruz 11:00-11:30 to dysfunction" Coffee break Valérie Doyère (FR), L2 Colegio de América Special Lecture L5 Elsevier BBR Lecture L7 Argiro Vatakis (GR) and Elizabeth Phelps Barbara Sahakian Tania Singer 11:30-12:30 Elzbieta Szelag (PL) Changing fear Depression and resilience: Insights Social emotions from the Lens of social from cognitive, neuroimaging and neuroscience (8:00-14:30) Giralda I-II psychopharmacological studies Giralda I-II Giralda I-II Poster Session #1 Poster Session #2 Poster Session #3 12:30-15:30 Santa Cruz Posters and Exhibition Area Posters and Exhibition Area Posters and Exhibition Area Welcome (15:00-15:30) Floor -1 and Floor -2 Floor -1 and Floor -2 Floor -1 and Floor -2 Giralda I-II
    [Show full text]